P0886 : Efficacy and safety of grazoprevir/elbasvir +/- RBV for 12 weeks in patients with HCV G1 or G4 infection who previously failed peginterferon/RBV: C-edge treatment-experienced trial

Paul Y. Kwo, Barbara Haber, Cheng‐Yuan Peng et al.|Journal of Hepatology|2015

Cited by 39